Key Highlights

  • Aterian (NASDAQ:ATER) reported a third-quarter net loss of USD 2.75 million, compared with USD 2.28 million a year earlier, after USD 2.91 million of income from discontinued operations offset part of the continuing loss.
  • The company completed the sale of its marquee brands to Trademark Global on July 17, 2026 for USD 18.0 million in cash, and repaid its MidCap Credit Facility in full on the same date.
  • A first contingent value right distribution of USD 12.4 million was paid on October 2, 2026, leaving only USD 1.5 million of unrestricted cash at September 30, 2026.
  • Management concluded there is substantial doubt about continuing as a going concern, and Nasdaq issued a minimum bid price notice on September 2, 2026 with compliance due by March 1, 2027.

A Quarter Reshaped by the Sale of Its Main Brands

Aterian (NASDAQ:ATER) filed its Quarterly Report on November 16, 2026 for the period ended September 30, 2026. The company sells home, kitchen, air quality and personal care goods mainly through Amazon, Walmart and Target. On July 17, 2026 it closed the sale of Mueller Living, PurSteam, hOmeLabs, Squatty Potty, Healing Solutions and Photo Paper Direct to Trademark Global for USD 18.0 million in cash, subject to purchase price adjustments. Those brands are now reported as discontinued operations, so continuing net Revenue was only USD 31 thousand in the quarter, against USD 27 thousand a year earlier. Loss from continuing operations widened to USD 5.66 million from USD 3.00 million, while income from discontinued operations of USD 2.91 million left a net loss of USD 2.75 million, or USD 0.09 per share.

Where the Sale Proceeds Went

Most of the cash was not kept by Aterian (NASDAQ:ATER). A Dividend of contingent value rights, distributed on August 17, 2026, entitles holders to pro rata cash from the net proceeds of the asset sale, after Debt and transaction costs, a USD 1.0 million operating reserve and up to USD 6.0 million for specified liabilities. The obligation was recognized at a Fair Value of USD 12.9 million, and the first payment of USD 12.4 million went out on October 2, 2026. It also sold Preferred Shares to David E. Lazar for USD 7.0 million, giving him about 95.8% of voting securities. On September 25, 2026 he sold his preferred interests, which converted into 241,861,970 common shares, leaving him with about 3.1%.

Going Concern Doubt, Listing Notice and a Thin Remaining Business

The Balance Sheet shows cash of USD 1.50 million, restricted cash of USD 13.50 million, and total Assets of USD 18.05 million at September 30, 2026, compared with USD 29.57 million at December 31, 2025. Operating expenses from continuing operations rose to USD 4.42 million from USD 2.77 million, and nine-month cash used in operations was USD 8.48 million. Management said the remaining brands, mainly Vremi and Xtava, operate at limited scale, and it is exploring new Business opportunities that depend on raising capital. A September 2, 2026 Nasdaq letter found the stock below the USD 1.00 minimum bid, with a 180-day compliance period ending March 1, 2027. As of November 13, 2026 the company had 261,882,422 common shares outstanding.

Where Things Stand

Management itself says substantial doubt remains, even after Aterian (NASDAQ:ATER) sold the core of its business for USD 18.0 million. Most net proceeds are earmarked for contingent value right holders, with USD 12.4 million already paid, so little is available to fund operations. Unrestricted cash was USD 1.50 million, the remaining brands are small, and a Nasdaq bid price deadline falls on March 1, 2027. The next markers are further contingent value right distributions, any new business transaction, a possible financing and the listing outcome.